Submission Deadline: September 5th, 2018

Publication Date: November 2018

Special Issue on Cancer Biomarker

 In Journal of Cancer Therapy (JCT, ISSN Online: 2151-1942)

Detailed information about this journal: Indexing, Editorial Board, Author’s Guidelines

A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology. Ideally, such biomarkers can be assayed in non-invasively collected biofluids like blood or serum.

We sincerely welcome scholar and expert with relative academic backgrounds to submit original research paper or review paper to this special issue on Cancer Biomarker. Potential topics or areas include, but are not limited to:

• BRCA1 and BRCA2 in ovarian cancer
• Braf V600E mutation in melanoma
• EGFR-targeted therapies
• HER2 expression in breast cancer
• PSA screening for prostate cancer
• Predictive cancer biomarkers
• Biomarkers for diagnosis and prognosis

Submission Methods:

Submit a paper to this special issue or regular issue of our any journal via Paper Submission System or attach paper in an email sent to submission.entrance1@scirp.org (please indicate the name of our journal or special issue; any inquiry is also welcome).

Friendly tip: please bookmark this page in your web browser if you consider contributing to our journal or special issue in the near future.

Selected Published Articles in JCT journal       

Check More Articles in JCT

Search Articles in the whole site

All Journals by subject

LKB1, A New Biomarker in Breast Cancer

Hanine Lattouf, Coralie Poulard, Isabelle Treilleux, Nader Hussein, Mona Diab-Assaf, Muriel Le Romancer

Correlation of Urinary Engrailed-2 Levels to Tumour Volume and Pathological Stage in Men Undergoing Radical Prostatectomy

Hardev Pandha, Saqib Javed, Prasanna Sooriakumaran, Simon Bott, Bruce Montgomery, Anthony Hutton, Christopher Eden, Christopher Eden, Stephen E. Langley, Richard Morgan

Markers for Diagnosis and Progression in Bladder Cancer

Josep M. Gaya, Juan Palou, Oscar Rodríguez, Humberto Villavicencio

The Prognostic Importance of EGFR and COX-2 Expression in Cervix Cancer Stages IIb-IVa

Parvin Adimi, Karina Dahl Steffensen, Doris Schledermann, Eva Rye Rasmussen, Anders Jakobsen

Phase II Study of Carboplatin and Pemetrexed Followed by Gefitinib for Patients with Advanced Non-Small Cell Lung Cancer Harboring Sensitive EGFR Mutation

Saki Manabe, Fumihiro Oshita, Shuji Murakami, Tetsuro Kondo, Haruhiro Saito, Takeshi Kaneko, Kouzo Yamada

Estimation of PSA Half-Life Following Salvage Radiation Therapy

Ajay B. Patel, Katherine S. Tzou, Michael G. Heckman, Colleen S. Thomas, Richard J. Lee, Nitesh Paryani, Thomas M. Pisansky, Jennifer L. Peterson, Robert C. Miller, Stephen J. Ko, Laura A. Vallow, Steven J. Buskirk

The Use of PSA Doubling Time to Predict Prognosis and the Use of PSA Response to Assess the Success for Prostate Cancer Patients Undergoing Docetaxel Chemotherapy

Sarp K. Keskin, Asif Yildirim, Cengiz Canakci, Ismail Ulus, Ramazan Gokhan Atis, Turhan Caskurlu

Check Other Open Special Issues

Lung Cancer

Melanoma Research

Cancer Metastasis

Cancer Chemotherapy

Editorial Assistant

JCT Editorial Office